Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid

Cell Physiol Biochem. 2004;14(3):167-76. doi: 10.1159/000078108.

Abstract

Aim of the present study was to elucidate the regulation of the mitogen activated protein (MAP) kinase cascades as well as the cross-talk between the various MAP kinase isoforms (ERK1/2, SAPK and p38) after stimulation of vascular smooth muscle cells (VSMC) with low density lipoprotein (LDL), 100 microg/ml or lysophosphatidic acid (LPA), 5 microg/ml. Furthermore, the role of the intracellular free Ca(2+) concentration ([Ca(2+)](i)) on the activation of the MAP kinase isoforms as well as on the protein expression of MAP kinase phosphatase (MKP)-1 was investigated. The methods used were Western blot analysis, immunoprecipitation and LDL isolation. Involvement of G(i)-proteins on LDL- and LPA-induced activation of the MAP kinase isoforms was examined by treatment of VSMC with pertussis toxin (PTX),100 ng/ml. LDL as well as LPA induced an activation of SAPK and p38 MAP kinase in a PTX-sensitive manner. The ERK1/2, SAPK and p38 MAP kinase activation was a Ca(2+)-dependent process, most likely regulated through modulation of MKP-1 protein expression. Inhibition of ERK1/2 by PD 98059 completely abolished LDL- and LPA-induced activation of SAPK, whereas the activation of p38 MAP kinase was not affected. We conclude, that [Ca(2+)](i) regulates the PTX-sensitive LDL- and LPA-induced stimulation of the MAP kinase cascades, probably via inhibition of the MKP-1 protein expression.

MeSH terms

  • Animals
  • Aorta / cytology
  • Aorta / metabolism*
  • Calcium Signaling / drug effects
  • Cell Cycle Proteins / metabolism*
  • Cells, Cultured
  • Dual Specificity Phosphatase 1
  • Enzyme Activation / drug effects
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Flavonoids / pharmacology
  • GTP-Binding Protein alpha Subunits, Gi-Go / metabolism
  • Gene Expression Regulation, Enzymologic / drug effects
  • Humans
  • Immediate-Early Proteins / metabolism*
  • Isoenzymes / metabolism
  • Lipoproteins, LDL / pharmacology*
  • Lysophospholipids / pharmacology*
  • MAP Kinase Signaling System / drug effects*
  • MAP Kinase Signaling System / physiology
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism*
  • Myocytes, Smooth Muscle / metabolism*
  • Pertussis Toxin / pharmacology
  • Phosphoprotein Phosphatases / metabolism*
  • Phosphorylation / drug effects
  • Protein Phosphatase 1
  • Protein Tyrosine Phosphatases / metabolism*
  • Rats
  • Rats, Inbred WKY

Substances

  • Cell Cycle Proteins
  • Flavonoids
  • Immediate-Early Proteins
  • Isoenzymes
  • Lipoproteins, LDL
  • Lysophospholipids
  • Pertussis Toxin
  • Extracellular Signal-Regulated MAP Kinases
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • DUSP1 protein, human
  • Dual Specificity Phosphatase 1
  • Dusp1 protein, rat
  • Protein Tyrosine Phosphatases
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • lysophosphatidic acid
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one